Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22

Johnson & Johnson CEO: 'We ended 2018 with great results'

In an interview on CNBC's Mad Money, Johnson & Johnson CEO Alex Gorsky said: "We ended 2018 with great results... We could not be more proud of Esketamine... One of the most exciting parts of my job is seeing technology being integrated with healthcare... Less than 5% of surgeries are performed by a robot, we think that can be greater."

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

JNJ Johnson & Johnson
$136.40

2.13 (1.59%)

02/14/19
FBCO
02/14/19
NO CHANGE
Target $151
FBCO
Outperform
Auris strengthens Johnson & Johnson's robotics program, says Credit Suisse
Credit Suisse analyst Vamil Divan says the Auris Health deal brings to Johnson & Johnson (JNJ) an attractive collection of robotic surgery assets, including 3 FDA-cleared robotic systems, a pipeline of additional applications and technologies, as well as significant robotics IP from both Auris and Hansen. Auris also brings substantial R&D and commercialization expertise related to robotic surgery systems, not least of which is Fred Moll - founder of Intuitive Surgical (ISRG) -, who is expected to remain with the program for the next 2-3 years, if not longer, the analyst adds. Divan reiterates an Outperform rating and $151 target on Johnson & Johnson, and views the Auris deal as an incremental near-term positive, with potentially significant long-term positive impact as the company's robotic surgery strategy unfolds.
02/13/19
PIPR
02/13/19
NO CHANGE
Target $625
PIPR
Overweight
Intuitive Surgical thesis intact after J&J buys Auris Health, says Piper Jaffray
Piper Jaffray analyst JP McKim reiterated an Overweight rating on Intuitive Surgical (ISRG) following this morning's announcement that Johnson & Johnson (JNJ) will buy Auris Health, with "robotics visionary" Dr. Fred Moll joining J&J upon completion of the deal. In a research note to investors, McKim says the deal doesn't really change his thesis on Intuitive Surgical, and believes the price J&J is paying "shows investors how much they should be valuing ISRG's Ion platform."
02/05/19
PIPR
02/05/19
NO CHANGE
Target $161
PIPR
Overweight
Piper says argenx cusatuzumab study could enable registration if responses hold
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $161 price target on argenx (ARGX) after the company announced a collaboration agreement with Halozyme (HALO). In a research note to investors, Tenthoff says that an ongoing Phase II study of cusatuzumab, which was licensed to Janssen (JNJ) after demonstrating a 92% response rate in AML at ASH, could enable registration if responses hold. The company will host an R&D Day in NYC on May 16 to introduce ARGX-117 and also expects the company will introduce ARGX-118.
01/28/19
PIPR
01/28/19
NO CHANGE
Target $38
PIPR
Overweight
MorphoSys weakness on patent ruling a buying opportunity, says Piper Jaffray
MorphoSys (MOR) shares are indicating down 5% this morning after the U.S. District Court sided against the company and ruled three of its patents invalid in a summary judgement of its lawsuit against Johnson & Johnson's (JNJ) Janssen this weekend, Piper Jaffray analyst Danielle Brill tells investors in a research note. The analyst is not surprised by the outcome and had low expectations for MorphoSys winning the case. The invalidated patents do not impact MorphoSys' drug MOR-202, and "very little has been lost" for the company, Brill writes. As such, she recommends buying the stock on today's weakness. The analyst keeps an Overweight rating on MorphoSys with a $38 price target.

TODAY'S FREE FLY STORIES

CAL

Caleres

$25.72

-0.11 (-0.43%)

15:34
03/21/19
03/21
15:34
03/21/19
15:34
Options
Caleres options imply 11.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

CURLF

Curaleaf Holdings

$0.00

(0.00%)

, CVS

CVS Health

$57.28

1.11 (1.98%)

15:28
03/21/19
03/21
15:28
03/21/19
15:28
Hot Stocks
Curaleaf Holdings spikes 22% after report of CBD products pact with CVS »

Shares of Curaleaf…

CURLF

Curaleaf Holdings

$0.00

(0.00%)

CVS

CVS Health

$57.28

1.11 (1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

LYG

Lloyds Banking

$3.27

-0.115 (-3.40%)

15:27
03/21/19
03/21
15:27
03/21/19
15:27
Options
Puts lead calls 140:1 in Lloyds Banking as shares underperform sector »

Puts lead calls 140:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVZ

Invesco

$19.88

0.16 (0.81%)

15:21
03/21/19
03/21
15:21
03/21/19
15:21
Conference/Events
Invesco management to meet with Morgan Stanley »

Meeting to be held In New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 28

    Mar

BV

BrightView

$15.34

-0.23 (-1.48%)

15:20
03/21/19
03/21
15:20
03/21/19
15:20
Hot Stocks
BrightView under investigation for potential securities laws violations »

Thornton Law Firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

XHB

SPDR Homebuilders

$38.38

0.82 (2.18%)

15:20
03/21/19
03/21
15:20
03/21/19
15:20
Options
Aggressive call buying in SPDR Homebuilders Fund as the sector sees strength »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:20
03/21/19
03/21
15:20
03/21/19
15:20
General news
Canada CPI preview »

Canada CPI preview:…

15:20
03/21/19
03/21
15:20
03/21/19
15:20
General news
Canada retail sales preview »

Canada retail sales…

DLAKY

Lufthansa

$0.00

(0.00%)

15:19
03/21/19
03/21
15:19
03/21/19
15:19
Conference/Events
Lufthansa management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

JEF

Jefferies Financial Group

$19.35

0.04 (0.21%)

15:19
03/21/19
03/21
15:19
03/21/19
15:19
Options
Jefferies Financial Group options imply 4.0% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

NEXA

Nexa Resources

$12.46

-0.22 (-1.74%)

15:17
03/21/19
03/21
15:17
03/21/19
15:17
Conference/Events
Nexa Resources management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
03/21/19
03/21
15:17
03/21/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
03/21/19
03/21
15:16
03/21/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:15
03/21/19
03/21
15:15
03/21/19
15:15
General news
Canada CPI preview »

Canada CPI preview:…

SPY

SPDR S&P 500 ETF Trust

$284.73

3.29 (1.17%)

, SPX

S&P 500

$0.00

(0.00%)

15:14
03/21/19
03/21
15:14
03/21/19
15:14
Periodicals
DoubleLine's Gundlach surprised by Fed's dovish double-down, CNBC says »

DoubleLine Capital CEO…

SPY

SPDR S&P 500 ETF Trust

$284.73

3.29 (1.17%)

SPX

S&P 500

$0.00

(0.00%)

QQQ

Invesco QQQ Trust

$182.53

2.79 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$57.40

0.64 (1.13%)

15:12
03/21/19
03/21
15:12
03/21/19
15:12
Conference/Events
Thomson Reuters management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

15:10
03/21/19
03/21
15:10
03/21/19
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

USB

U.S. Bancorp

$49.78

-0.59 (-1.17%)

, WFC

Wells Fargo

$49.91

-0.48 (-0.95%)

15:06
03/21/19
03/21
15:06
03/21/19
15:06
Hot Stocks
Bank stocks sit out rally, mirroring concern for broader economy »

Shares of financial…

USB

U.S. Bancorp

$49.78

-0.59 (-1.17%)

WFC

Wells Fargo

$49.91

-0.48 (-0.95%)

MS

Morgan Stanley

$43.45

0.425 (0.99%)

JPM

JPMorgan

$102.96

-1.58 (-1.51%)

C

Citi

$64.24

-0.05 (-0.08%)

GS

Goldman Sachs

$195.08

0.81 (0.42%)

BAC

Bank of America

$28.33

-0.3 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 12

    Apr

  • 12

    Apr

  • 15

    Apr

  • 16

    Apr

  • 16

    Apr

  • 17

    Apr

  • 23

    Apr

  • 24

    Apr

  • 28

    May

  • 13

    Jul

  • 13

    Jul

  • 12

    Oct

ZUO

Zuora

$24.08

0.36 (1.52%)

15:04
03/21/19
03/21
15:04
03/21/19
15:04
Options
Zuora options imply 16.5% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 23

    Apr

SMG

Scotts Miracle-Gro

$79.39

2.27 (2.94%)

15:02
03/21/19
03/21
15:02
03/21/19
15:02
Hot Stocks
Scotts Miracle-Gro extends partnership with Major League Baseball »

The Scotts Company and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

BA

Boeing

$374.14

-2.27 (-0.60%)

15:00
03/21/19
03/21
15:00
03/21/19
15:00
Periodicals
Boeing to slow work on 737 planes for 3 days next week, Bloomberg reports »

In an emailed statement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 28

    May

DRI

Darden

$116.09

7.47 (6.88%)

, BLMN

Bloomin' Brands

$19.73

0.37 (1.91%)

14:54
03/21/19
03/21
14:54
03/21/19
14:54
Upgrade
Darden, Bloomin' Brands rating change at Gordon Haskett »

Darden upgraded to Hold…

DRI

Darden

$116.09

7.47 (6.88%)

BLMN

Bloomin' Brands

$19.73

0.37 (1.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

NSA

National Storage

$28.29

0.5 (1.80%)

14:54
03/21/19
03/21
14:54
03/21/19
14:54
Conference/Events
National Storage management to meet with Morgan Stanley »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

AZO

AutoZone

$999.06

17.86 (1.82%)

14:51
03/21/19
03/21
14:51
03/21/19
14:51
Conference/Events
AutoZone management to meet with Morgan Stanley »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

XLK

Technology Select Sector SPDR

$75.09

1.85 (2.53%)

14:50
03/21/19
03/21
14:50
03/21/19
14:50
Options
Timely call buy in SPDR Technology Fund »

Timely call buy in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.